Online citations, reference lists, and bibliographies.

Degradation Of Aqueous Pharmaceuticals By Ozonation And Advanced Oxidation Processes: A Review

K. Ikehata, Naeimeh Jodeiri Naghashkar, M. Gamal El-Din
Published 2006 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
A vast number of pharmaceuticals have been detected in surface water and drinking water around the world, which indicates their ineffective removal from water and wastewater using conventional treatment technologies. Concerns have been raised over the potential adverse effects of pharmaceuticals on public health and aquatic environment. Among the different treatment options, ozonation and advanced oxidation processes are likely promising for efficient degradation of pharmaceuticals in water and wastewater. Recent progress of advanced oxidation of aqueous pharmaceuticals is reviewed in this paper. The pharmaceuticals and non-therapeutic medical agent of interest include antibiotics, anticonvulsants, antipyretics, beta-blockers, cytostatic drugs, H2 antagonists, estrogenic hormone and contraceptives, blood lipid regulators, and X-ray contrast media.
This paper references
10.1080/0306731021000075384
Analysis of Acidic Drugs in Swiss Wastewaters
B. Soulet (2002)
10.1016/J.WATRES.2003.09.028
Advanced oxidation of the pharmaceutical drug diclofenac with UV/H2O2 and ozone.
Davide Vogna (2004)
10.1021/ES048331P
Triplet-sensitized photodegradation of sulfa drugs containing six-membered heterocyclic groups: identification of an SO2 extrusion photoproduct.
Anne L. Boreen (2005)
Initial Treatment of Epilepsy—Special Issues in Treating the Elderly’’, Neurology
G. K. Bergey (2004)
10.1016/J.WATRES.2003.10.058
Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration.
M. Clara (2004)
10.1016/S0378-4274(03)00091-2
Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slices.
K. Soejima (2003)
10.1080/01919518908552432
Aqueous Ozonation Of Fatty Acids
G. Reynolds (1989)
Ötker, ‘‘Treatment of Pharmaceutical Wastewater Containing Antibiotics by O3 and O3/ H2O2 Processes’’, Chemosphere
I. Akmehmet Balcio glu (2003)
10.1016/J.WATRES.2004.09.016
Photocatalytic degradation of carbamazepine, clofibric acid and iomeprol with P25 and Hombikat UV100 in the presence of natural organic matter (NOM) and other organic water constituents.
T. E. Doll (2005)
10.1080/09593332208618273
Partial Oxidation by Ozone to Remove Recalcitrance from Wastewaters - a Review
A. Alvares (2001)
10.1111/j.2042-7158.1985.tb04922.x
The fate of pharmaceutical chemicals in the aquatic environment.
M. Richardson (1985)
Reissman, ‘‘Persistence of Pharmaceutical Compounds and Other Organic Wastewater Contaminants in a Conventional Drinking-Water Treatment Plant’
P. E. Stackelberg (2004)
10.1021/ES050794N
Photo-fenton degradation of diclofenac: identification of main intermediates and degradation pathway.
L. Perez-Estrada (2005)
Akmehmet Balcio  glu , I . and M . Ötker , ‘ ‘ Treatment of Pharmaceutical Wastewater Containing Antibiotics by O 3 and O 3 / H 2 O 2 Processes
A. Alum (2003)
10.1016/S1010-6030(02)00435-5
Kinetic investigation on UV and UV/H2O2 degradations of pharmaceutical intermediates in aqueous solution
A. López (2003)
10.1080/01919519908547260
Ozonation of cytostatics in water medium. Nitrogen bases
R. P. Rey (1999)
10.1016/S0021-9673(01)01266-3
Pharmaceuticals in groundwaters analytical methods and results of a monitoring program in Baden-Württemberg, Germany.
F. Sacher (2001)
Cimetidine and Ranitidine’’, Environ
D. E. Latch (2003)
Photolytic and TiO2-Assisted Photodegradation of Aqueous Solutions of Tetracycline
A. D. Paola (2004)
10.1016/B978-0-08-057123-2.50011-9
CHAPTER 7: – Drug Metabolism
R. Silverman (1992)
10.1080/01919510590945732
Aqueous Pesticide Degradation by Ozonation and Ozone-Based Advanced Oxidation Processes: A Review (Part II)
K. Ikehata (2005)
10.1016/J.JHAZMAT.2003.07.001
Ozonation and H2O2/UV treatment of clofibric acid in water: a kinetic investigation.
R. Andreozzi (2003)
10.1006/EESA.1998.1759
Environmental risk assessment for the widely used iodinated X-ray contrast agent iopromide (Ultravist).
T. Steger-Hartmann (1999)
10.1021/ES025896H
Oxidation of pharmaceuticals during ozonation and advanced oxidation processes.
M. M. Huber (2003)
17b-Estrodial Degradation by TiO2 Photocatalysis as Means of Reducing Estrogenic Activity’
Y. Ohko (2002)
10.1021/ES048396S
Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study.
M. M. Huber (2005)
10.1080/01919510208901630
Ozone: Science & Engineering The First 23 Years
Barry L. Loeb Editor-in-Chief (2002)
10.2166/WST.2002.0764
Evaluation of estrogen-like activity on sewage treatment processes using recombinant yeast.
K. Onda (2002)
10.1016/S0045-6535(03)00757-4
Kinetic and chemical assessment of the UV/H2O2 treatment of antiepileptic drug carbamazepine.
Davide Vogna (2004)
‘ Drugs and Drug Metabolites as Environmental Contaminants — Chlorophenoxyisobutyrate and Salicylic - Acid inSewageWaterEffluent ’ ’ , LifeSci
R. Hirsch (1977)
Implications for the Water Industry’’, Environ
S. A. Snyder (2003)
10.1016/J.CHEMOSPHERE.2004.09.028
Mineralization of paracetamol in aqueous medium by anodic oxidation with a boron-doped diamond electrode.
E. Brillas (2005)
10.1016/J.SCITOTENV.2004.03.015
Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant.
P. Stackelberg (2004)
10.1021/JO025604V
Advanced oxidation chemistry of paracetamol. UV/H(2)O(2)-induced hydroxylation/degradation pathways and (15)N-aided inventory of nitrogenous breakdown products.
Davide Vogna (2002)
10.1016/J.JENVMAN.2004.06.007
Combined chemical and biological oxidation of penicillin formulation effluent.
I. A. Alaton (2004)
Contamination of Hospital Wastewater with Hazardous Compounds as Defined by 7 a WHG
S. Gartiser (2005)
Sulfa Drugs Containing Five-Membered Heterocyclic Groups’’, Environ
A. L. Boreen (2004)
10.1021/ES0353053
Photochemical fate of sulfa drugs in the aquatic environment: sulfa drugs containing five-membered heterocyclic groups.
Anne L. Boreen (2004)
A Case Study from Finland’’, Waste Manage
J. H. Tanskanen (1998)
10.1081/ESE-100106248
OCCURRENCE OF IODINATED X-RAY CONTRAST MEDIA IN DOMESTIC EFFLUENTS AND THEIR FATE DURING INDIRECT POTABLE REUSE
J. Drewes (2001)
Naproxen, Diclofenac, Clofibric Acid, and Ibuprofen’’, Aquat
J. L. Packer (2003)
10.1016/J.CHROMA.2004.04.005
Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry.
J. D. Cahill (2004)
10.1080/01919510490885370
Evaluation of Estrogenicity for 17 β-Estradiol Decomposition During Ozonation
S. Kim (2004)
10.1897/03-319
Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions.
Jeong-Wook Kwon (2004)
10.1016/j.etap.2005.01.008
Screening estrogenic oxidized by-products by combining ER binding and ultrafiltration.
Jianghua Liu (2005)
10.1213/00000539-195101000-00003
The Merck Manual of Diagnosis and Therapy
M. Beers (1982)
10.1016/S0169-409X(96)00423-1
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.
C. Lipinski (1997)
10.1002/TOX.20018
Oxidation of bisphenol A, 17β‐estradiol, and 17α‐ethynyl estradiol and byproduct estrogenicity
A. Alum (2004)
10.1016/J.YRTPH.2003.10.002
Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy.
S. Castiglioni (2004)
10.1002/1521-401X(200207)30:1<24::AID-AHEH24>3.0.CO;2-O
Production of Drinking Water from Highly Contaminated Surface Waters: Removal of Organic, Inorganic, and Microbial Contaminants Applying Mobile Membrane Filtration Units
Thomas Heberer (2002)
10.2166/wst.1997.0338
Source separated urine-nutrient and heavy metal content, water saving and faecal contamination
Håkan N. Jönsson (1997)
Identification and Kinetic Study of Major Oxidation Products’’, Environ
D. C. McDowell (2005)
10.1080/10408340490273753
Fate and Analysis of Pharmaceutical Residues in the Aquatic Environment
J. Dębska (2004)
Identification of an SO2 Extrusion Photoproduct’’, Environ
A. L. Boreen (2005)
10.1021/ES015757K
Removal of pharmaceuticals during drinking water treatment.
T. Ternes (2002)
10.1139/S05-046
Aqueous pesticide degradation by hydrogen peroxide/ultraviolet irradiation and Fenton-type advanced oxidation processes: a review
K. Ikehata (2006)
10.1002/aheh.19960240206
Belastung von Krankenhausabwasser mit gefährlichen Stoffen im Sinne 7a WHG
S. Gartiser (1996)
10.1080/10643380590956966
Human Pharmaceuticals in Wastewater Treatment Processes
O. A. H. Jones (2005)
10.1016/S0048-9697(00)00461-7
Occurrence of triiodinated X-ray contrast agents in the aquatic environment.
A. Putschew (2000)
10.1016/S0378-4274(98)00328-2
Xenoendorine disrupters--environmental impacts.
J. Sumpter (1998)
Azarnoff, ‘‘Drugs and Drug Metabolites as Environmental Contaminants—Chlorophenoxyisobutyrate and Salicylic-Acid inSewageWaterEffluent’’,LifeSci
C. Hignite (1977)
10.1080/109158198226675
Endocrine-Modulating Substances in the Environment: Estrogenic Effects of Pharmaceutical Products
L. D. Arcand-Hoy (1998)
10.7326/0003-4819-108-5-781_2
The Merck Manual of Diagnosis and Therapy
L. Lipsey (1988)
Science & Engineering — The First 23 years’’, Ozone Sci
B. L. Loeb (2002)
10.1016/S0043-1354(02)00075-1
Accelerated mineralization of the drug Diclofenac via Fenton reactions in a concentric photo-reactor.
M. Raviña (2002)
10.1016/S0165-9936(03)01105-1
Analysis and removal of emerging contaminants in wastewater and drinking water
M. Petrovíc (2003)
10.1016/S0048-9697(98)00334-9
Behavior and occurrence of estrogens in municipal sewage treatment plants--I. Investigations in Germany, Canada and Brazil.
T. Ternes (1999)
10.1007/S10800-005-1630-Y
Removal of drugs in aqueous systems by photoassisted degradation
M. Addamo (2005)
10.1016/S0021-9673(02)00088-2
Analysis of acidic drugs in the effluents of sewage treatment plants using liquid chromatography-electrospray ionization tandem mass spectrometry.
Xiu-Sheng Miao (2002)
10.1016/S0926-3373(00)00197-1
Mineralization of aniline and 4-chlorophenol in acidic solution by ozonation catalyzed with Fe2+ and UVA light
Roser Sauleda (2001)
10.1016/S0378-4274(02)00041-3
Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data.
T. Heberer (2002)
10.1016/J.CHEMOSPHERE.2004.10.014
Ozonation of Procaine Penicillin G formulation effluent Part I: Process optimization and kinetics.
İ. Arslan-Alaton (2005)
10.1021/ES035119X
Environmental risk assessment of paroxetine.
V. Cunningham (2004)
10.1080/01919518908552447
Aqueous ozonation of pesticides: a review
G. Reynolds (1989)
10.1089/109287503768335931
Pharmaceuticals, Personal Care Products, and Endocrine Disruptors in Water: Implications for the Water Industry
S. Snyder (2003)
A National Reconnaissance’’, Environ
D. W. Kolpin (2002)
10.1016/J.JHAZMAT.2004.08.011
Biological treatability of raw and ozonated penicillin formulation effluent.
E. Cokgor (2004)
10.1093/JAC/DKH325
Resistance in the environment.
K. Kuemmerer (2004)
10.1021/ES050043L
Ozonation of carbamazepine in drinking water: identification and kinetic study of major oxidation products.
D. C. Mcdowell (2005)
Photocatalytic Degradation of Cefradine in Water over Immobilized TiO_2 Catalyst in Continuous-Flow Reactor
Fan Shan-Hu (2002)
10.1016/S0043-1354(01)00500-0
Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity.
R. Andreozzi (2002)
10.1016/J.TIBTECH.2005.02.001
Pharmaceuticals: a threat to drinking water?
O. Jones (2005)
Aniline Degradation by Electrocatalytic Oxidation’’, Chemosphere
Y. J. Li (2003)
10.1111/j.1432-1033.1986.tb09441.x
Reaction of cimetidine with Fenton reagent. A biomimetic model for the mixed-function oxidase drug metabolism.
S. Zbaida (1986)
Malato, ‘‘Decomposition of Diclofenac by Solar Driven Photocatalysis at Pilot Plant Scale’
L. A. Pérez-Estrada (2005)
Tashma, ‘‘Reaction of Cimetidine with Fenton Reagent — A Biomimetic Model for the Mixed-Function Oxidase DrugMetabolism’
S. Zbaida (1986)
UV and H2O2/UV degradation of a pharmaceutical intermediate in aqueous solution.
A. López (2002)
10.1080/01919510490885334
Determination of Ozonation Rate Constants for Lincomycin and Spectinomycin
Z. Qiang (2004)
10.1016/J.APCATB.2003.09.023
Photocatalytic transformations of sulphonamides on titanium dioxide
P. Calza (2004)
10.1016/J.WATRES.2004.11.029
Cross-flow microfiltration with periodical back-washing for photocatalytic degradation of pharmaceutical and diagnostic residues-evaluation of the long-term stability of the photocatalytic activity of TiO2.
T. E. Doll (2005)
10.1016/S0045-6535(97)00354-8
Occurrence, fate and effects of pharmaceutical substances in the environment--a review.
B. Halling-Sørensen (1998)
The Organic Chemistry of Drug Design and Drug Action
R B Silverman (1992)
10.1002/9783527610884.CH5
Photochemical Processes of Water Treatment
T. Oppenländer (2007)
Chemical degradation of wastes of antineoplastic agents. 2: Six anthracyclines: idarubicin, doxorubicin, epirubicin, pirarubicin, aclarubicin, and daunorubicin.
M. Castegnaro (1997)
10.1021/ES011500A
17 beta-estradiol degradation by TiO2 photocatalysis as a means of reducing estrogenic activity.
Y. Ohko (2002)
10.1016/S0045-6535(02)00534-9
Treatment of pharmaceutical wastewater containing antibiotics by O3 and O3/H2O2 processes.
I. Akmehmet Balcıoğlu (2003)
Pharmaceuticals, Hormones, and Other Organic Wastewater Contaminants in U.S. Streams, 1999-2000: A National Reconnaissance
D. A.N (2002)
10.1061/(ASCE)0733-9372(2002)128:3(253)
Removal of Antibiotics from Surface and Distilled Water in Conventional Water Treatment Processes
C. Adams (2002)
10.1016/J.JHAZMAT.2004.04.009
Pre-treatment of penicillin formulation effluent by advanced oxidation processes.
İ. Arslan-Alaton (2004)
10.1016/S0043-1354(99)00338-3
Oxidative treatment of pharmaceuticals in water
C. Zwiener (2000)
A Review, (Part I)’’ Ozone: Sci
K. Ikehata (2005)
10.1016/J.WATRES.2003.11.009
Kinetic study of photocatalytic degradation of carbamazepine, clofibric acid, iomeprol and iopromide assisted by different TiO2 materials--determination of intermediates and reaction pathways.
T. E. Doll (2004)
10.1016/S0021-9673(02)01528-5
Determination of acidic drugs in sewage water by gas chromatography-mass spectrometry as tert.-butyldimethylsilyl derivatives.
I. Rodríguez (2003)
10.1139/S02-020
Advanced technologies in water and wastewater treatment
H. Zhou (2001)
10.1021/ES991118M
Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment
T. Ternes (2000)
Removal of Organic, Inorganic and Microbial Contaminants Applying Mobile Membrane Filtration Units’’, Acta Hydrochim
T. Heberer (2002)
10.1080/01919510490482160
Degradation of Recalcitrant Surfactants in Wastewater by Ozonation and Advanced Oxidation Processes: A Review
K. Ikehata (2004)
10.1016/J.MEMSCI.2003.12.034
Estrogenic hormone removal from wastewater using NF/RO membranes
L. Nghiem (2004)
10.1016/S0043-1354(02)00570-5
Ozonation: a tool for removal of pharmaceuticals, contrast media and musk fragrances from wastewater?
T. Ternes (2003)
10.2166/WST.2004.0304
Effects of advanced oxidation processes (AOPs) on the toxicity of a mixture of pharmaceuticals.
R. Andreozzi (2004)
10.1007/s00027-003-0671-8
Photochemical fate of pharmaceuticals in the environment: Naproxen, diclofenac, clofibric acid, and ibuprofen
J. Packer (2003)
10.1016/S0043-1354(02)00460-8
Paracetamol oxidation from aqueous solutions by means of ozonation and H2O2/UV system.
R. Andreozzi (2003)
10.1007/s004200050124
Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan
S. Hansel (1996)
10.1212/WNL.63.10_SUPPL_4.S40
Initial treatment of epilepsy
G. Bergey (2004)
10.1111/j.1444-0938.2007.00102.x
The Merck Manual of Diagnosis and Therapy, 17th Edition
Martin H. Levinson (2000)
10.1021/ES030653Q
Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada.
Xiu-Sheng Miao (2004)
d’Ischia, ‘‘Kinetic and Chemical Assessment of the UV/H2O2 Treatment of Antiepileptic Drug Carbamazepine’’, Chemosphere
D. Vogna (2004)
10.1016/S0048-9697(98)00337-4
Occurrence of antibiotics in the aquatic environment.
R. Hirsch (1999)
10.1021/ES0340782
Photochemical fate of pharmaceuticals in the environment: cimetidine and ranitidine.
Douglas E. Latch (2003)
A Review’’, Ozone: Sci
K. Ikehata (2004)
Occurrence and Fate of Pharmaceutically Active Compounds in the Environment, A Case Study: Ho¨je River in Sweden
D Bendz (2005)
10.1016/S0045-6535(01)00144-8
Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review.
K. Kuemmerer (2001)
10.1016/J.JPBA.2004.01.001
The photocatalytic process as a tool to identify metabolitic products formed from dopant substances: the case of buspirone.
P. Calza (2004)
10.1021/ES9705811
Occurrence of the Pharmaceutical Drug Clofibric Acid and the Herbicide Mecoprop in Various Swiss Lakes and in the North Sea
H. Buser (1998)
10.1021/ES010149Q
UV absorbance dependent toxicity of acridine to the marine diatom Phaeodactylum tricornutum.
S. Wiegman (2002)
The Ozonation of Amoxicillin’’, J
R. Andreozzi (2005)
10.1016/J.CATTOD.2005.03.005
REMOVAL OF SELECTED PERSISTENT ORGANIC POLLUTANTS BY HETEROGENEOUS PHOTOCATALYSIS IN WATER
T. E. Doll (2005)
10.2166/WST.2004.0303
Removal of hormones and pharmaceuticals in the Advanced Water Recycling Demonstration Plant in Queensland, Australia.
S. Khan (2004)
Idarubicin, Doxorubicin, Epirubicin, Pirarubicin, Aclarubicin, and Daunorubicin’’, Int
M. Castegnaro (1997)
10.1016/J.JHAZMAT.2005.03.004
Antibiotic removal from wastewaters: the ozonation of amoxicillin.
R. Andreozzi (2005)
10.1016/S0165-9936(01)00078-4
Analytical methods for the determination of pharmaceuticals in aqueous environmental samples
T. Ternes (2001)
A Review of Recent Research Data’’, Toxicol
T. Heberer (2002)
Brillas, ‘‘Mineralization of Aniline and 4-Chlorophenol in Acidic Solution by Ozonation Catalyzed with Fe andUVALight’’,Appl
R. Sauleda (2001)
10.1002/AHEH.200390014
Determination of Antibiotic Residues in Manure, Soil, and Surface Waters
T. Christian (2003)
10.1016/S0048-9697(98)00336-2
Analysis and occurrence of estrogenic hormones and their glucuronides in surface water and waste water in The Netherlands.
A. Belfroid (1999)
10.1016/J.JBIOTEC.2004.03.033
How to avoid pharmaceuticals in the aquatic environment.
T. Larsen (2004)
10.1021/ES035413P
Degradation of endocrine disrupting chemicals bisphenol A, ethinyl estradiol, and estradiol during UV photolysis and advanced oxidation processes.
E. Rosenfeldt (2004)
10.1016/J.JPBA.2005.04.048
Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS.
K. A. Johnson (2005)
10.1016/J.JHAZMAT.2005.03.005
Adsorption and degradation of enrofloxacin, a veterinary antibiotic on natural zeolite.
Havva Merih Otker (2005)
Pharmaceutical Retention Mechanisms by Nanofiltration Membranes
L O N
10.1002/ETC.5620210302
The potential for estradiol and ethinylestradiol degradation in English rivers.
M. Jürgens (2002)
10.2175/106143002X140387
Ozonation of municipal wastewater effluents.
P. Paraskeva (2002)
10.1177/0734242X9801600602
Waste streams, costs and emissions in municipal solid waste management: a case study from Finland
J. Tanskanen (1998)
10.1016/S0043-1354(98)00099-2
Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus
T. Ternes (1998)
10.1080/01919510590925220
Aqueous Pesticide Degradation by Ozonation and Ozone-Based Advanced Oxidation Processes: A Review (Part I)
K. Ikehata (2005)
10.1016/J.JPHOTOCHEM.2004.03.016
Photo-Fenton-like and photo-fenton-like oxidation of Procaine Penicillin G formulation effluent
İ. Arslan-Alaton (2004)
10.1080/09593332108618090
Evaluation of Advanced Sewage Treatment Processes for Reuse of Wastewater Using Bioassays
Kenichi Shishida (2000)
‘ Occurrence andFate of Pharmaceutically Active Compounds in the Environment , A Case Study : HöjeRiver in Sweden
D. Bendz (2003)
10.1016/S0920-5861(99)00102-9
Advanced oxidation processes (AOP) for water purification and recovery
R. Andreozzi (1999)
10.1201/9780203509173
Ozone Reaction Kinetics for Water and Wastewater Systems
F. Beltrán (2003)
Goldbach, ‘‘Determination of Antibiotic Residues in Manure, Soil, and Surface Waters’
T. Christian (2003)
10.1021/AC048512+
Simultaneous analysis of multiple classes of antibiotics by ion trap LC/MS/MS for assessing surface water and groundwater contamination.
Angela L Batt (2005)
10.1080/02652030400028001
Confirmatory method for the analysis of carbadox and olaquindox in porcine feedingstuffs using LC-electrospray MS–MS
M. Hutchinson (2005)
10.2166/WST.2001.0315
Photochemical oxidation of iodized X-ray contrast media (XRC) in hospital wastewater.
M. Sprehe (2001)
10.2166/WS.2002.0041
Pharmaceuticals degradation by UV and UV/H2O2 treatments
A. Bozzi (2002)
A Pilot Study’’, Environ
M. M. Huber (2005)
10.1021/ES035205X
Removal of estrogenic activity and formation of oxidation products during ozonation of 17alpha-ethinylestradiol.
M. M. Huber (2004)
10.1016/S0043-1354(01)00109-9
Membrane filtration of two sulphonamides in tertiary effluents and subsequent adsorption on activated carbon.
C. Hartig (2001)
10.1016/C2009-0-64537-2
The Organic Chemistry of Drug Design and Drug Action
R. Silverman (1992)
10.1016/J.JHAZMAT.2005.03.012
Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
D. Bendz (2005)
10.1016/J.SCITOTENV.2004.11.008
Degradation of estrone in aqueous solution by photo-Fenton system.
Xianghua Feng (2005)
10.1016/0024-3205(77)90329-0
Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicyclic acid in sewage water effluent.
C. Hignite (1977)
10.1016/J.CATTOD.2005.03.013
Decomposition of diclofenac by solar driven photocatalysis at pilot plant scale
L. Perez-Estrada (2005)
10.1515/ci.2003.25.4.31b
Photochemical purification of water and air
T. Oppenländer (2003)
Cyclophosphamide, Ifosfamide and Melphalan’’, Int
S. Hansel (1997)
10.1016/S0045-6535(03)00590-3
Aniline degradation by electrocatalytic oxidation.
Y. Li (2003)
10.1016/S0048-9697(03)00138-4
Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
G. Boyd (2003)



This paper is referenced by
Ozone against mycotoxins and pesticide residues in food: Current applications and perspectives
F. Trombete (2016)
10.1016/J.CHERD.2015.04.003
Quantitative prediction of generation of hydroxyl radicals from ozone microbubbles
Snigdha Khuntia (2015)
10.1016/J.WATRES.2014.09.051
Evaluation of the persistence of transformation products from ozonation of trace organic compounds - a critical review.
U. Hübner (2015)
10.1007/s10971-011-2639-9
Photocatalytic degradation of metoprolol in water suspension of TiO2 nanopowders prepared using sol–gel route
Maja Šćepanović (2011)
10.1016/J.CJCHE.2015.08.030
Adsorption and degradation of norfloxacin by a novel molecular imprinting magnetic Fenton-like catalyst
Mingjie Huang (2015)
10.1080/01919512.2015.1095632
Comparative Experimental Study between Surface and Volume DBD Ozone Generator
Kamel Nassour (2016)
10.1007/s10311-015-0540-4
Redox processes in water remediation
Praveen K. Tandon (2015)
10.1016/J.JPHOTOCHEM.2018.04.014
Individual and simultaneous degradation of the antibiotics sulfamethoxazole and trimethoprim in aqueous solutions by Fenton, Fenton-like and photo-Fenton processes using solar and UV radiations
Jesús Iván Martinez-Costa (2018)
10.1016/j.chemosphere.2014.08.016
Oxidative degradation study on antimicrobial agent ciprofloxacin by electro-Fenton process: kinetics and oxidation products.
M. Yahya (2014)
Advances in Removal of Aqueous Pharmaceuticals and Personal Care Products
Donghai Wu (2016)
10.4172/2155-6199.1000264
Laboratory Experiment of Advanced Oxidation Process Coupled Coagulation, Flocculation, and Biological Treatment
G Bhaskar (2014)
10.1016/j.watres.2010.06.053
Solar Fenton and solar TiO2 catalytic treatment of ofloxacin in secondary treated effluents: evaluation of operational and kinetic parameters.
I. Michael (2010)
10.1016/j.chemosphere.2010.02.060
Removal of sulfadiazine, sulfamethizole, sulfamethoxazole, and sulfathiazole from aqueous solution by ozonation.
T. Garoma (2010)
10.1016/j.watres.2017.05.018
Effect of operational and water quality parameters on conventional ozonation and the advanced oxidation process O3/H2O2: Kinetics of micropollutant abatement, transformation product and bromate formation in a surface water.
M. Bourgin (2017)
10.1016/j.ecoenv.2008.12.002
Physico-chemical, microbiological and ecotoxicological evaluation of a septic tank/Fenton reaction combination for the treatment of hospital wastewaters.
J. Berto (2009)
10.1016/j.jhazmat.2013.11.038
Enhanced ozonation degradation of di-n-butyl phthalate by zero-valent zinc in aqueous solution: performance and mechanism.
G. Wen (2014)
10.1016/J.CEJ.2008.11.019
Oxidation of dissolved organic matter in the effluent of a sewage treatment plant using ozone combined with hydrogen peroxide (O3/H2O2)
Roberto Rosal (2009)
10.1007/978-90-481-3509-7_10
Photochemical Transformation of Pharmaceuticals in the Aquatic Environment: Reaction Pathways and Intermediates
I. Konstantinou (2010)
10.1016/J.BEJ.2012.04.011
Operation of stirred tank reactors (STRs) and fixed-bed reactors (FBRs) with free and immobilized Phanerochaete chrysosporium for the continuous removal of pharmaceutical compounds
A. I. Rodarte-Morales (2012)
10.1039/C6RA26287B
Enhanced electrochemical oxidation of phenol by boron-doped diamond nanowire electrode
Choul Ho Lee (2017)
10.1007/s11664-018-6591-0
Needle-Like La-Doped MgO Photocatalyst: Synthesis, Characterization and Photodegradation of Flumequine Antibiotic Under UV Irradiation
Ali İmran Vaizoğullar (2018)
10.7202/038330AR
Procédés d’oxydation avancée dans le traitement des eaux et des effluents industriels: Application à la dégradation des polluants réfractaires
F. Zaviska (2009)
10.1016/j.chemosphere.2016.09.072
Prussian blue analogue derived magnetic carbon/cobalt/iron nanocomposite as an efficient and recyclable catalyst for activation of peroxymonosulfate.
K. Lin (2017)
AlgaeBioGas Algal treatment of biogas digestate and feedstock production D 4 . 2 Alternative solutions review
(2015)
10.1080/01919512.2018.1431521
Free Radical and Direct Ozone Reaction Competition to Remove Priority and Pharmaceutical Water Contaminants with Single and Hydrogen Peroxide Ozonation Systems
F. Beltrán (2018)
10.1002/aoc.5728
Intramolecular orbital engineered hetero bimetallic Ce‐Fe MOF with reduced transition energy and enhanced visible light property
Aneek Kuila (2020)
10.1016/j.jhazmat.2018.10.058
Functionalized magnetic nanomaterials for rapid and effective adsorptive removal of fluoroquinolones: Comprehensive experimental cum computational investigations.
R. Malik (2019)
Nanostructred Catalysts for Photo-oxidation of Endocrine Disrupting Chemicals
Neval Baycan (2019)
10.1016/j.jes.2017.04.037
Enhanced ozonation degradation of atrazine in the presence of nano-ZnO: Performance, kinetics and effects.
Xiangjuan Yuan (2017)
10.1016/j.chemosphere.2017.11.065
Electro-oxidation of Ofloxacin antibiotic by dimensionally stable Ti/RuO2 anode: Evaluation and mechanistic approach.
R. Kaur (2018)
Comprehensive Assessment of the Effects of Ozone and Uv Radiation on the Molecular Weights and Optical Properties of Natural Water and Wastewater Effluent Dissolved Organic Matter
Allison Paul (2012)
10.1016/J.ELECTACTA.2010.11.071
Graphite: An active or an inactive anode?
Matthew Rueffer (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar